Jasper Therapeutics Inc (JSPR)
23.82
0.00 (0.00%)
USD |
NASDAQ |
May 23, 16:00
23.80
-0.02
(-0.08%)
Pre-Market: 20:00
Jasper Therapeutics Total Liabilities (Quarterly): 12.73M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 12.73M |
| December 31, 2023 | 16.45M |
| September 30, 2023 | 16.27M |
| June 30, 2023 | 13.96M |
| March 31, 2023 | 13.56M |
| December 31, 2022 | 12.37M |
| Date | Value |
|---|---|
| September 30, 2022 | 11.54M |
| June 30, 2022 | 11.58M |
| March 31, 2022 | 12.44M |
| December 31, 2021 | 24.14M |
| September 30, 2021 | 28.61M |
| December 31, 2020 | 58.49M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
11.54M
Minimum
Sep 2022
58.49M
Maximum
Dec 2020
19.35M
Average
13.76M
Median
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 25.29M |
| Theriva Biologics Inc | 14.61M |
| Oragenics Inc | 0.9087M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 125.96M |
| Shareholders Equity (Quarterly) | 113.23M |